ODYSSEY THERAPEUTICS REVEALS PRICING FOR LARGER INITIAL PUBLIC OFFERING
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Should l Buy ODTX?
Source: moomoo
Company Announcement: Odysssey Therapeutics has announced the pricing of its upsized initial public offering (IPO).
IPO Details: The IPO will involve a larger number of shares being offered to the public than initially planned.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ODTX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ODTX
Wall Street analysts forecast ODTX stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 18.000
Low
Averages
High
Current: 18.000
Low
Averages
High

No data
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Company Overview: Odysssey Therapeutics has announced a significant upsizing of its initial public offering (IPO).
IPO Details: The company is offering 15.5 million shares at a price of $18.00 per share.
See More
Company Announcement: Odysssey Therapeutics has announced the pricing of its upsized initial public offering (IPO).
IPO Details: The IPO will involve a larger number of shares being offered to the public than initially planned.
See More





